Disease-modifying activity of progesterone in the hippocampus kindling model of epileptogenesis

Neuropharmacology

Volumn 59, Issue 7-8, 2010, Pages 573-581

  Reddy, Doodipala Samba ^a   Gangisetty, Omkaram ^a   Briyal, Seema ^a  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

Disease modifying; Epileptogenesis; Kindling; Neurosteroid; Progesterone; Progesterone receptor; Seizure

Indexed keywords

PROGESTERONE; PROGESTERONE RECEPTOR;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; EPILEPTOGENESIS; FEMALE; HIPPOCAMPUS; KINDLING; MOTOR PERFORMANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REBOUND; SEDATION; SEIZURE;

ANIMALS; ANTICONVULSANTS; EPILEPSY; FEMALE; HIPPOCAMPUS; KINDLING, NEUROLOGIC; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROGESTERONE; RECEPTORS, PROGESTERONE; SEIZURES;

EID: 77958113561     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2010.08.017     Document Type: Article

References (74)

1. Albertson T.E., Joy R.M., Stark L.G. A pharmacological study in the kindling model of epilepsy. Neuropharmacology 1984, 23:1117-1123.
2. Bäckström T., Zetterlund B., Blom S., Romano M. Effect of intravenous progesterone infusions on the epileptic discharge frequency in women with partial epilepsy. Acta Neurol. Scandinavia 1984, 69:240-248.
3. Belelli D., Bolger M.B., Gee K.W. Anticonvulsant profile of the progesterone metabolite 5α-pregnan-3α-ol-20-one. Eur. J. Pharmacol. 1989, 166:325-329.
4. Biagini G., Baldelli E., Longo D., Pradelli L., Zini I., Rogawski M.A., Avoli M. Endogenous neurosteroids modulate epileptogenesis in a model of temporal lobe epilepsy. Exp. Neurol. 2006, 201:519-524.
5. Biagini G., Longo D., Baldelli E., Zoli M., Rogawski M.A., Bertazzoni G., Avoli M. Neurosteroids and epileptogenesis in the pilocarpine model: evidence for a relationship between P450scc induction and length of the latent period. Epilepsia 2009, 50(Suppl. 1):53-58.
6. Brandt C., Glien M., Gastens A.M., Fedrowitz M., Bethmann K., Volk H.A., Potschka H., Löscher W. Prophylactic treatment with levetiracetam after status epilepticus: lack of effect on epileptogenesis, neuronal damage, and behavioral alterations in rats. Neuropharmacology 2007, 53:207-221.
7. Brinton R.D., Thompson R.F., Foy M.R., Baudry M., Wang J., Finch C.E., Morgan T.E., Pike C.J., Mack W.J., Stanczyk F.Z., Nilsen J. Progesterone receptors: form and function in brain. Front. Neuroendocrinol. 2008, 29:313-339.
8. Christensen J., Kjeldsen M.J., Anderson H., Friis M.L., Sidenious P. Gender differences in epilepsy. Epilepsia 2005, 46:956-960.
9. Coughenour A.G., McLean J.R., Parker R.B. A new device for the rapid measurement of impaired motor function in mice. Pharmacol. Biochem. Behav. 1977, 6:351-353.
10. Craig C.R. Anticonvulsant activity of steroids: separability of anticonvulsant from hormonal effects. J. Pharmacol. Exp. Ther. 1966, 153:337-343.
11. Cutler S.M., Pettus E.H., Hoffman S.W., Stein D.G. Tapered progesterone withdrawal enhances behavioral and molecular recovery after traumatic brain injury. Exp. Neurol. 2005, 195:423-429.
12. Cutler S.M., Cekic M., Miller D.M., Wali B., VanLandingham J.W., Stein D.G. Progesterone improves acute recovery after traumatic brain injury in the aged rat. J. Neurotrauma 2007, 24:1475-1486.
13. DeCoster M., Lambeau G., Lazdunski M., Bazan N.G. Secreted phospholiase A2 potentiates glutamate-induced calcium increase and cell death in primary neuronal cultures. J. Neurosci. Res. 2002, 67:634-645.
14. Dürmüller N., Craggs M., Meldrum B.S. The effect of the non-NMDA receptor antagonist GYKI 52466 and NBQX and the competitive NMDA receptor antagonist D-CPPene on the development of amygdala kindling and on amygdala-kindled seizures. Epilepsy Res. 1994, 17:167-174.
15. Edwards H.E., Burnham W.M., Mendonca A., Bowlby D.A., MacLusky N.J. Steroid hormones affect limbic afterdischarge thresholds and kindling rates in adult female rats. Brain Res. 1999, 838:136-150.
16. Edwards H.E., Epps T., Carlen P.L., MacLusky N.J. Progestin receptors mediate progesterone suppression of epileptiform activity in tetanized hippocampal slices in vitro. Neuroscience 2000, 101:895-906.
17. Edwards H.E., Mo V., Burnham W.M., MacLusky N.J. Gonadectomy unmasks an inhibitory effect of progesterone on amygdala kindling in male rats. Brain Res. 2001, 889:260-263.
18. Engel J., Pedley T.A., Aicardy J., Dichter M.A. Epilepsy: A Comprehensive Textbook 2007, Lippincott: Williams & Wilkins. second ed.
19. Frye C.A., Scalise T.J. Anti-seizure effects of progesterone and 3α,5α-THP in kainic acid and perforant pathway models of epilepsy. Psychoneuroendocrinology 2000, 25:407-420.
20. Frye C.A., Rhodes M.E., Walf A., Harney J. Progesterone reduces pentylenetetrazol-induced ictal activity of wild-type mice but not those deficient in type I 5α-reductase. Epilepsia 2002, 43(Suppl 5):14-17.
21. Gee K.W., McCauley L.D., Lan N.C. A putative receptor for neurosteroids on the GABA-A receptor complex: the pharmacological properties and therapeutic potential of epalons. Crit. Rev. Neurobiol. 1995, 9:207-227.
22. Gibson C.L., Gray L.J., Bath P.M., Murphy S.P. Progesterone for the treatment of experimental brain injury; a systematic review. Brain 2008, 131:318-328.
23. Goddard G.V., McIntyre D.C., Leech C.K. A permanent change in brain function resulting from daily electrical stimulation. Exp. Neurol. 1969, 25:295-330.
24. Hauser W.A., Annegers J.F., Kurland L.T. Incidence of epilepsy and unprovoked seizures in RochesterMinnesota during 1935-1984. Epilepsia 1993, 34:453-468.
25. He J., Evans C.O., Hoffman S.W., Oyesiku N.M., Stein D.G. Progesterone and allopregnanolone reduce inflammatory cytokines after traumatic brain injury. Exp. Neurol. 2004, 189:404-412.
26. A receptors. Pharmacol. Ther. 2007, 116:20-34.
27. Herzog A.G., Fowler K.M. Sensitivity and specificity of the association between catamenial seizure patterns and ovulation. Neurology 2008, 70:486-487. The NIH Progesterone Trial Study Group.
28. Herzog A.G., Klein P., Ransil B.J. Three patterns of catamenial epilepsy. Epilepsia 1997, 38:1082-1088.
29. Herzog A.G. Progesterone therapy in women with complex partial and secondary generalized seizures. Neurology 1995, 45:1600-1662.
30. Herzog A.G. Progesterone therapy in women with epilepsy: a 3-year follow-up. Neurology 1999, 52:1917-1918.
31. Holmes G.L., Weber D.A. The effect of progesterone on kindling: a developmental study. Brain Res. 1984, 318:45-53.
32. Holmes G.L., Weber D.A., Kloczko N., Zimmerman A.W. Relationship of endocrine function to inhibition of kindling. Brain Res. 1984, 318:55-59.
33. A receptors through two discrete transmembrane sites. Nature 2006, 444:486-489.
34. Jacobs M.P., Leblanc G.G., Brooks-Kayal A., Jensen F.E., Lowenstein D.H., Noebels J.L., Spencer D.D., Swann J.W. Curing epilepsy: progress and future directions. Epilepsy Behav. 2009, 14:438-445.
35. Jiang N., Chopp M., Stein D., Feit H. Progesterone is neuroprotective after transient middle cerebral artery occlusion in male rats. Brain Res. 1996, 735:101-107.
36. Kaminski R.M., Livingood M.R., Rogawski M.A. Allopregnanolone analogs that positively modulate GABA receptors protect against partial seizures induced by 6-Hz electrical stimulation in mice. Epilepsia 2004, 45:864-867.
37. Koenig H., Schumacher M., Ferzaz B., Do Thi A.N., Ressouches A., Guennoun R., Jung-Testas I., Robel P., Akwa Y., Baulieu E.E. Progesterone synthesis and myelin formation by Schwann cells. Science 1995, 268:1500-1503.
38. Kokate T.G., Banks M.K., Magee T., Yamaguchi S., Rogawski M.A. Finasteride, a 5a-reductase inhibitor, blocks the anticonvulsant activity of progesterone in mice. J. Pharmacol. Exp. Ther. 1999, 288:679-684.
39. Lonsdale D., Burnham W.M. The anticonvulsant effects of progesterone and 5α-dihydroprogesterone on amygdala-kindled seizures in rats. Epilepsia 2003, 44:1494-1499.
40. Lonsdale D., Nylen K., Burnham W.M. The anticonvulsant effects of progesterone and its metabolites on amygdala-kindled seizures in male rats. Brain Res. 2006, 1101:110-116.
41. Löscher W., Hönack D., Rundfeldt C. Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy. J. Pharmacol. Exp. Ther. 1998, 284:474-479.
42. Löscher W. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Res. 2002, 50:105-123.
43. Lydon J.P., DeMayo F.J., Funk C.R., Mani S.K., Hughes A.R., Montgomery C.A., Shyamala G., Conneely O.M., O'Malley B.W. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev. 1995, 9:2266-2278.
44. McHugh J.C., Delanty N. Epidemiology and classification of epilepsy: gender comparisons. Int. Rev. Neurobiol. 2008, 83:11-26.
45. McNamara J.O., Morrisett R., Nadler J.V. Recent advances in understanding mechanisms of the kindling model. Adv. Neurol. 1992, 57:555-560.
46. Meffre D., Pianos A., Liere P., Eychenne B., Cambourg A., Schumacher M., Stein D.G., Guennoun R. Steroid profiling in brain and plasma of male and pseudopregnant female rats after traumatic brain injury: analysis by gas chromatography/mass spectrometry. Endocrinology 2007, 148:2505-2517.
47. Mohammad S., Abolhassan A., Pourgholami M.H. Evaluation of the anticonvulsant profile of progesterone in male amygdala-kindled rats. Epilepsy Res. 1998, 30:195-202.
48. Moran M.H., Smith S.S. Progesterone withdrawal I: pro-convulsant effects. Brain Res. 1998, 807:84-90.
49. Nissinen J., Large C.H., Stratton S.C., Pitkänen A. Effect of lamotrigine treatment on epileptogenesis: an experimental study in rat. Epilepsy Res. 2004, 58:119-132.
50. Patel M. Mitochondrial dysfunction and oxidative stress: cause and consequences of epileptic seizures. Free Radic. Biol. Med. 2004, 37:1951-1962.
51. Pitkänen A., Immonen R.J., Gröhn O.H., Kharatishvili I. From traumatic brain injury to posttraumatic epilepsy: what animal models tell us about the process and treatment options. Epilepsia 2009, 50(Suppl 2):21-29.
52. Pitkänen A. Drug-mediated neuroprotection and antiepileptogenesis: animal data. Neurology 2002, 59:S27-S33.
53. Racine R.J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 1972, 32:281-294.
54. Reddy D.S., Mohan A. Progesterone receptor-mediated seizure susceptibility in female mice. Soc. Neurosci. 2010, Absr # 2010-S-3658.
55. Reddy D.S., Kim H.Y., Rogawski M.A. Neurosteroid withdrawal model of perimenstrual catamenial epilepsy. Epilepsia 2001, 42:328-336.
56. Reddy D.S., Castenada D.A., O'Malley B.W., Rogawski M.A. Antiseizure activity of progesterone and neurosteroids in progesterone receptor knockout mice. J. Pharmacol. Exp. Therap 2004, 310:230-239.
57. Reddy D.S., O'Malley B.W., Rogawski M.A. Anxiolytic activity of progesterone in progesterone receptor knockout mice. Neuropharmacology 2005, 48:14-24.
58. Reddy D.S. The role of neurosteroids in the pathophysiology and treatment of catamenial epilepsy. Epilepsy Res. 2009, 85:1-30.
59. Rogawski M.A., Kurzman P.S., Yamaguchi S.I., Li H. Role of AMPA and GluR5 kainate receptors in the development and expression of amygdala kindling in the mouse. Neuropharmacology 2001, 40:28-35.
60. Roof R.L., Hall E.D. Gender differences in acute CNS trauma and stroke: neuroprotective effects of estrogen and progesterone. J. Neurotrauma 2000, 17:367-388.
61. Roof R.L., Duvdevani R., Braswell L., Stein D.G. Progesterone facilitates cognitive recovery and reduces secondary neuronal loss caused by cortical contusion injury in male rats. Exp. Neurol. 1994, 129:64-69.
62. Rupprecht R., Reul J.M., Trapp T., van Steensel B., Wetzel C., Damm K., Zieglgansberger W., Holsboer F. Progesterone receptor-mediated effects of neuroactive steroids. Neuron 1993, 11:523-530.
63. Selye H. The antagonism between anesthetic steroid hormones and pentamethylenetetrazol (metrazol). J. Lab. Clin. Med. 1942, 27:1051-1053.
64. Shen H., Sabaliauskas N., Sherpa A., Fenton A.A., Stelzer A., Aoki C., Smith S.S. A critical role for alpha4betadelta GABA-A receptors in shaping learning deficits at puberty in mice. Science 2010, 327(5972):1515-1518.
65. Silver J.M., Shin C., McNamara J.O. Antiepileptogenic effects of conventional anticonvulsants in the kindling model of epilepsy. Ann. Neurol. 1991, 29:356-363.
66. Stein D.G., Sayeed I. Is progesterone worth consideration as a treatment for brain injury. Am. J. Roentgenol 2010, 194:20-22.
67. Temkin N.R. Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials. Epilepsia 2001, 42:515-524.
68. Vezzani A. Inflammation and epilepsy. Epilepsy Curr. 2005, 5:1-6.
69. Wada J.A., Mizoguchi T., Osawa T. Secondarily generalized convulsive seizures induced by daily amygdaloid stimulation in rhesus monkeys. Neurology 1978, 28:1026-1036.
70. Wahnschaffe U., Löscher W. Lack of changes in seizure susceptibility during the estrous cycle in kindled rats. Epilepsy Res. 1992, 13:199-204.
71. Walker M.C., White H.S., Sander J.W. Disease modification in partial epilepsy. Brain 2002, 125:1937-1950.
72. Wright D.W., Kellermann A.L., Hertzberg V.S., Clark P.L., Frankel M., Goldstein F.C., Salomone J.P., Dent L.L., Harris O.A., Ander D.S., Lowery D.W., Patel M.M., Denson D.D., Gordon A.B., Wald M.M., Gupta S., Hoffman S.W., Stein D.G. ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann. Emerg. Med. 2007, 49:391-402.
73. Xiao G., Wei J., Yan W., Wang W., Lu Z. Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial. Crit. Care 2008, 12(2):R61.
74. Yagami T., Ueda K., Asakura K., Hayasaki-Kajiwara Y., Nakazato H., Sakaeda T., Hata S., Kuroda T., Takasu N., Hori Y. Group IB secretory phospholipase A2 induces neuronal cell death via apoptosis. J. Neurochem. 2002, 81:449-461.